Quality evaluation of HPV vaccine-related online messages in China: a cross-sectional study

• Váldodahkkit: Wanzhou Wang (Dahkki), Jinliang Lyu (Dahkki), Mintao Li (Dahkki), Yunjing Zhang (Dahkki), Zhihu Xu (Dahkki), Yuanyuan Chen (Dahkki), Jiangjie Zhou (Dahkki), Shengfeng Wang (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: Taylor & Francis Group, 2021-04-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Since 2019, three types of HPV vaccine have been approved for use in mainland China. High quality messages are crucial for vaccine acceptance, but little is known about the online information quality concerning HPV vaccine in China. "HPV vaccine" and "cervical cancer vaccine" in...